Myeloid-related protein 8 induces self-tolerance and cross-tolerance to bacterial infection via TLR4- and TLR2-mediated signal pathways

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Coveney, Andrew P ^a   Wang, Wei ^a,b   Kelly, Justin ^a   Liu, Jing Hua ^a,b   Blankson, Siobhan ^a   Wu, Qiong Di ^a   Redmond, H Paul ^a   Wang, Jiang Huai ^a  

^a University College Cork and INFANT Centre   (Ireland)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; S100A8 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL; BACTERIAL INFECTION; CECUM; DRUG EFFECTS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLAMMATION; LIGATION; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; PUNCTURE; SEPSIS; SIGNAL TRANSDUCTION; TIME FACTOR;

ANIMALS; BACTERIAL INFECTIONS; CALGRANULIN A; CECUM; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; LIGATION; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MICE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEINS; PUNCTURES; SEPSIS; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84940829747     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13694     Document Type: Article

References (61)

1. Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5 (2007).
2. Cavassani, K. A. et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 205, 2609-2621 (2008).
3. Millar, D. G. et al. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat. Med. 9, 1469-1476 (2003).
4. Park, J. S. et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370-7377 (2004).
5. Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487-496 (2007).
6. Matzinger, P. The danger model: a renewed sense of self. Science 296, 301-305 (2002).
7. Vogl, T. et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13, 1042-1049 (2007).
8. Basu, S., Binder, R. J., Suto, R., Anderson, K. M. & Srivastava, P. K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12, 1539-1546 (2000).
9. Rovere-Querini, P. et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5, 825-830 (2004).
10. Vabulas, R. M., Wagner, H. & Schild, H. Heat shock proteins as ligands of toll-like receptors. Curr. Top. Microbiol. Immunol. 270, 169-184 (2002).
11. Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195 (2002).
12. Vogl, T., Roth, J., Sorg, C., Hillenkamp, F. & Strupat, K. Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-Assisted laser desorption/ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 10, 1124-1130 (1999).
13. Viemann, D. et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105, 2955-2962 (2005).
14. Vogl, T. et al. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 104, 4260-4268 (2004).
15. Foell, D. & Roth, J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 50, 3762-3771 (2004).
16. Foell, D., Wittkowski, H., Vogl, T. & Roth, J. S100 proteins expressed in phagocytes: a novel group of damage-Associated molecular pattern molecules. J. Leukoc. Biol. 81, 28-37 (2007).
17. Roth, J., Vogl, T., Sorg, C. & Sunderkotter, C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 24, 155-158 (2003).
18. van Zoelen, M. A. et al. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am. J. Respir. Crit. Care Med. 180, 1098-1106 (2009).
19. Rammes, A. et al. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem. 272, 9496-9502 (1997).
20. Frosch, M. et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 43, 628-637 (2000).
21. Roth, J. et al. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 82, 1875-1883 (1993).
22. Giorgi, R. et al. Antinociceptive effect of the calcium-binding protein MRP-14 and the role played by neutrophils on the control of inflammatory pain. J. Leukoc. Biol. 64, 214-220 (1998).
23. Johne, B. et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol. Pathol. 50, 113-123 (1997).
24. Murthy, A. R., Lehrer, R. I., Harwig, S. S. & Miyasaki, K. T. In vitro candidastatic properties of the human neutrophil calprotectin complex. J. Immunol. 151, 6291-6301 (1993).
25. Sohnle, P. G., Collins-Lech, C. & Wiessner, J. H. Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J. Infect. Dis. 163, 187-192 (1991).
26. Steinbakk, M. et al. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 336, 763-765 (1990).
27. Yui, S., Mikami, M., Tsurumaki, K. & Yamazaki, M. Growth-inhibitory and apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: regulation by metal ions. J. Leukoc. Biol. 61, 50-57 (1997).
28. Lugering, N. et al. Immunohistochemical distribution and serum levels of the Ca(2+ )-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion 56, 406-414 (1995).
29. Lugering, N. et al. The myeloic related protein MRP8/14 (27E10 antigen)-usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur. J. Clin. Invest. 25, 659-664 (1995).
30. McCormick, M. M. et al. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J. Biol. Chem. 280, 41521-41529 (2005).
31. Abe, J. et al. Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J. Immunol. 174, 5837-5845 (2005).
32. Haga, H. J. et al. Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus 2, 47-50 (1993).
33. Youssef, P. et al. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J. Rheumatol. 26, 2523-2528 (1999).
34. Odink, K. et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330, 80-82 (1987).
35. Manitz, M. P. et al. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell Biol. 23, 1034-1043 (2003).
36. Hobbs, J. A. et al. Myeloid cell function in MRP-14 (S100A9) null mice. Mol. Cell Biol. 23, 2564-2576 (2003).
37. Raingeaud, J. et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-Activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426 (1995).
38. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G. & Siebenlist, U. Control of I kappa B-Alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485-1488 (1995).
39. Nathan, C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6, 173-182 (2006).
40. Modlin, R. L., Brightbill, H. D. & Godowski, P. J. The toll of innate immunity on microbial pathogens. N. Engl. J. Med. 340, 1834-1835 (1999).
41. Russell, J. A. Management of sepsis. N. Engl. J. Med. 355, 1699-1713 (2006).
42. Brown, M. A. & Jones, W. K. NF-kappaB action in sepsis: the innate immune system and the heart. Front. Biosci. 9, 1201-1217 (2004).
43. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998. 282, 2085-2088 (1998).
44. Hoshino, K. et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749-3752 (1999).
45. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997).
46. Aliprantis, A. O. et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736-739 (1999).
47. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M. & Kirschning, C. J. Peptidoglycan-And lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274, 17406-17409 (1999).
48. Wheeler, D. S. et al. Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock 30, 267-273 (2008).
49. Biswas, S. K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475-487 (2009).
50. Wang, J. H. et al. Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock. J. Immunol. 170, 14-18 (2003).
51. Austermann, J. et al. Alarmins MRP8 and MRP14 induce stress tolerance in phagocytes under sterile inflammatory conditions. Cell Rep. 9, 2112-2123 (2014).
52. Foster, S. L., Hargreaves, D. C. & Medzhitov, R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972-978 (2007).
53. Zarubin, T. & Han, J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15, 11-18 (2005).
54. Weighardt, H. et al. Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J. Immunol. 165, 4537-4543 (2000).
55. Alves-Filho, J. C. et al. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat. Med. 16, 708-712 (2010).
56. Zantl, N. et al. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect. Immun. 66, 2300-2309 (1998).
57. Liu, J., Buckley, J. M., Redmond, H. P. & Wang, J. H. ST2 negatively regulates TLR2 signaling, but is not required for bacterial lipoprotein-induced tolerance. J. Immunol. 184, 5802-5808 (2010).
58. Wahl, L. M., Wahl, S. M., Smythies, L. E. & Smith, P. D. Isolation of monocyte populations. Curr. Protoc. Immunol. 7, 7.6A (2006).
59. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65, 55-63 (1983).
60. O'Brien, G. C., Wang, J. H. & Redmond, H. P. Bacterial lipoprotein induces resistance to Gram-negative sepsis in TLR4-deficient mice via enhanced bacterial clearance. J. Immunol. 174, 1020-1026 (2005).
61. Buckley, J. M. et al. Increased susceptibility of ST2-deficient mice to polymicrobial sepsis is associated with an impaired bactericidal function. J. Immunol. 187, 4293-4299 (2011).